Defective CD3zeta chain expression in Herpesvirus saimiri (HVS)-derived T-cell lines in gastric adenocarcinoma

Cellular Immunology
Mercedes López-SantallaJosé M Martín-Villa

Abstract

Low expression of the CD3zeta chain has been reported in patients with cancer and it has been suggested that tumor-derived factors are involved in its downregulation. The expression of CD3zeta chain was measured in T-cell lines from patients with gastric adenocarcinoma and healthy volunteers and grown in vitro for several months and, hence, in the absence of any tumor-derived factors. T-cell lines of mucosal origin were obtained by Herpesvirus saimiri transformation from gastric cancer patients. The expression of CD3zeta and CD3epsilon was measured by flow cytometry and Western-blot analysis. Calcium mobilization and apoptosis rate were also measured. The levels of CD3zeta, but not CD3epsilon, chain on the cell surface were significantly reduced in T-cell lines derived from patients with gastric cancer when cultured in the absence of IL-2. Western-blot analysis of total cell extracts or lipid raft fractions confirmed this finding. Calcium mobilization, a measure of signal transduction, was reduced in T cell lines from patients with gastric cancer. We conclude that T cells from patients with cancer express lower levels of CD3zeta. This downregulation is not caused by a direct effect of tumor-derived factors but, rather, it appea...Continue Reading

References

Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·B BiesingerB Fleckenstein
May 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·A BauerE L Reinherz
Jul 22, 1998·Journal of Immunotherapy·T E ReichertT L Whiteside
Jul 8, 1999·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·C W KimY J Bang
Apr 20, 2000·The Journal of Biological Chemistry·D A Brown, E London
Aug 5, 2000·International Journal of Cancer. Journal International Du Cancer·A LetschC Scheibenbogen
Nov 1, 2000·Cell·M L Dustin, A C Chan
Jul 10, 2002·Trends in Immunology·Daniel M Davis
Jun 9, 2004·Cancer Immunology, Immunotherapy : CII·G Pawelec
Sep 3, 2004·Nature Reviews. Immunology·Michal Baniyash

❮ Previous
Next ❯

Citations

Sep 19, 2009·Expert Review of Anticancer Therapy·Ana Paula de Souza, Cristina Bonorino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.